Clinical and experimental obstetrics & gynecology 2013-01-01

Dihydrotestosterone may contribute to the development of migraine headaches.

J H Check, R Cohen

Index: Clin. Exp. Obstet. Gynecol. 40(2) , 217-8, (2013)

Full Text: HTML

Abstract

To evaluate the possibility that dihydrotestosterone (DHT) may play a role in the etiology of some people's migraine headaches.Finasteride 5 mg daily was given to a young woman with chronic migraines.The chronic migraine headaches almost completely disappeared shortly following therapy. However, symptoms returned shortly after stopping the finasteride due to dry eyes.DHT may be an etiologic factor in causing migraines since finasteride suppresses DHT secretion. Alternatively, the benefit could be related to some other property of finasteride possibly by increasing testosterone which may compete with estrogen at the blood vessel level.


Related Compounds

Related Articles:

Evidence for aldosterone-dependent growth of renal cell carcinoma.

2014-08-01

[Int. J. Exp. Pathol. 95(4) , 244-50, (2014)]

Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes.

2015-01-01

[Diabetes 64(1) , 236-42, (2015)]

Patient with purulent pericarditis: a case doomed to fail?

2013-01-01

[Kardiol. Pol. 71(2) , 176-8, (2013)]

A chrysin analog exhibited strong inhibitory activities against both PGE2 and NO production.

2011-09-01

[Am. J. Physiol. Regul. Integr. Comp. Physiol. 305(10) , R1133-40, (2013)]

Mineralocorticoid receptor agonists induce mouse aortic aneurysm formation and rupture in the presence of high salt.

2013-07-01

[Arterioscler. Thromb. Vasc. Biol. 33(7) , 1568-79, (2013)]

More Articles...